Skip to main content

Table 4 Patient needs at time of consultation

From: Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey

 

Percentage of quite/very important responsesa

p value**

AIT (N = 1083), %

No-AIT (N = 335), %

Total (N = 1418), %

To be relieved of all symptoms

96.1

92.4

95.2

0.020

To no longer have a runny or blocked nose

94.9

92.2

94.3

0.179

To be able to breathe through my nose more freely

92.1

89.4

91.5

0.296

To not have sneezing impulses

87.6

83.9

86.7

0.176

To have a treatment which is easy to use

84.2

76.9

82.5

0.006

To not experience eye, nose or palate stinging anymore

82.0

73.8

80.1

0.003

To have confidence in the therapy

82.8

70.2

79.9

<0.001

To experience more enjoyment of life

76.7

66.0

74.2

<0.001

To be able to sleep better

75.2

62.4

72.2

<0.001

To be able to concentrate better at work

73.1

66.0

71.4

0.042

To be able to stay outdoors without symptoms

72.8

66.7

71.3

0.033

To be able to engage in normal leisure activities

73.9

61.7

71.0

<0.001

To have no fear that the disease will become worse

72.4

61.2

69.7

0.001

To feel less tired or groggy

71.8

62.6

69.6

<0.001

To be more productive in everyday life

69.6

60.6

67.5

0.009

To not have burning or watery eyes anymore

67.6

57.2

65.2

0.002

To reduce the frequency of visits to the physician

68.3

54.3

65.0

<0.001

To feel more comfortable in public

58.4

54.2

57.4

0.229

To feel less burdened in your relationship

59.2

51.7

57.4

0.057

To spend less time on daily treatment

57.5

51.1

56.0

<0.001

To have fewer side effects

55.5

46.7

53.5

0.019

To feel less irritated

54.7

44.8

52.3

0.007

To have fewer out-of-pocket treatment expenses

53.

46.1

51.6

0.012

To feel less depressed

44.9

35.8

42.8

0.002

To be able to have a normal sex life

41.5

38.6

40.8

0.532

  1. Analysis of the patient needs questionnaires (PNQ) completed on the day of the consultation, corresponds to the needs of the patient (i.e. what he/she expected from a new therapeutic management of disease by her/his physician). Patient needs are ordered by decreasing importance in the total population. Needs are rated using a six-point scale from ‘not concerned’ to ‘very important’
  2. ** Chi squared test or Fisher’s exact test
  3. aPercentage of patients with needs corresponding to ‘quite important’ to ‘very important’ at allergen immunotherapy initiation